Literature DB >> 8278175

Foveal avascular zone in idiopathic juxtafoveolar telangiectasia.

A M Mansour1, A Schachat.   

Abstract

We measured angiographically the foveal avascular zone (FAZ) in 26 subjects with idiopathic juxtafoveolar telangiectasia (IJFT) and 27 control subjects. Quantitatively, FAZ was significantly smaller in IJFT (median = 0 mm2) than in controls (median = 0.405 mm2). Qualitatively, the telangiectasia in IJFT was temporal (92.5% of eyes) and appeared as microaneurysms interconnected with several capillaries, spider-shaped microaneurysms, or Coats'-like telangiectasia. IJFT is characterized by temporal telangiectasia and small FAZ.

Entities:  

Mesh：

Year:  1993        PMID： 8278175     DOI： 10.1159/000310399

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN： 0030-3755            Impact factor:   3.250


  9 in total

1.  Centripetal retinal capillary proliferation in idiopathic parafoveolar telangiectasis.

Authors:  Hideki Koizumi; Michael J Cooney; Anita Leys; Richard F Spaide
Journal:  Br J Ophthalmol       Date:  2007-12       Impact factor: 4.638

2.  Morphological Characteristics of Normal Foveal Avascular Zone by Optical Coherence Tomography Angiography.

Authors:  Zeiad Eldaly; Wael Soliman; Mohamed Sharaf; Ali Natag Reyad
Journal:  J Ophthalmol       Date:  2020-08-19       Impact factor: 1.909

3.  Idiopathic juxtafoveolar retinal telangiectasis: a current review.

Authors:  Sawsan R Nowilaty; Hanan N Al-Shamsi; Wajeeha Al-Khars
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07

Review 4.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

5.  Foveal avascular zone in macular branch retinal vein occlusion.

Authors:  M B Parodi; F Visintin; P Della Rupe; G Ravalico
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031

6.  Macular telangiectasia type 2 (MacTel) in a 34-year-old patient.

Authors:  Heleen Nicolai; Mieke Wirix; Leigh Spielberg; Anita Leys
Journal:  BMJ Case Rep       Date:  2014-09-23

7.  Comparison of observation, intravitreal bevacizumab, or pars plana vitrectomy for non-proliferative type 2 idiopathic macular telangiectasia.

Authors:  Eric J Sigler; John C Randolph; Jorge I Calzada; Steve Charles
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-09-06       Impact factor: 3.117

Review 8.  Multimodality imaging in macular telangiectasia 2: A clue to its pathogenesis.

Authors:  Lihteh Wu
Journal:  Indian J Ophthalmol       Date:  2015-05       Impact factor: 1.848

Review 9.  When is macular edema not macular edema? An update on macular telangiectasia type 2.

Authors:  Lihteh Wu
Journal:  Taiwan J Ophthalmol       Date:  2015-11-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.